Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by RealScientiston May 26, 2016 10:40pm
171 Views
Post# 24909006

RE:RE:RE:RE:Vanc Pharmaceuticals extends, reprices warrants

RE:RE:RE:RE:Vanc Pharmaceuticals extends, reprices warrantsIMO if management would have promoted the company and their progress, especially immediately following release of Q1 financials, they might have had their warrants forced exercised. Instead, they released nothing and the past few weeks have seen the stock price decrease pretty significantly. Everyone is pissed and rightly so. I can't wait to see what management has to say at the AGM in June. I think there will be a lot of voiced displeasure.

I'm not selling tomorrow. I'll hold and buy some more in the 20s. This will be back to the 40s and 50s  in a couple months after Q2. Management will get their warrants exercised in the next 6 months but it's just a shame they had to do it this way. GL everyone.
Bullboard Posts